Why the study?
Does point-of-care testing for troponin I reduce time to anti-ischemic therapy in patients with suspected NSTE-ACS presenting to the emergency department?
Population
860 patients presenting to the emergency department with suspected non-ST-segment elevation acute coronary…
Comparison
Point-of-care testing for troponin I measurement vs Central hospital laboratory testing for troponin…
Design
RCT, randomly allocated, open-label
Authors
Loading...
Accelerates anti-ischemic therapy for suspected NSTE-ACS in the ED; confirms POCT benefit versus central laboratory testing in RCT.
Does point-of-care testing for troponin I reduce time to anti-ischemic therapy in patients with suspected NSTE-ACS presenting to the emergency department?
Point-of-care troponin testing in the emergency department significantly reduces the time to anti-ischemic therapy for patients with suspected NSTE-ACS.
Renaud et al. (2008) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: